Insider · CIK 0001773461
Stephen L Silvestro
Files at OPRX (OptimizeRx Corp). First filing Oct 7, 2025, latest Oct 7, 2025.
In brief
Stephen L Silvestro files SEC Form 4 as CEO at OPRX (OptimizeRx Corp). Since Oct 7, 2025, Stephen L Silvestro has reported 0 open-market buys worth $0 and 1 open-market sell worth $30k, the latest filed on Oct 7, 2025.
A track record needs three past buys with six months of prices behind them; Stephen L Silvestro has 0, so none is measured yet.
The newest scored trade: sold $30k of OPRX on Oct 3, 2025, filed Oct 7, 2025, scored 15 (weak).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
OPRX: OptimizeRx Corp
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 15Weak | OPRXsell OptimizeRx Corp | $30k 1,620 shares | -1% | +390% from low-9% from high |
Transactions
Every row this insider has filed, 20 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 20, 2026 | OPRX OptimizeRx Corp | AGrant or award Common Stock | +79,200 | $0.00 | $0 | 262,751 | Aug 24, 2026 |
| Aug 21, 2026 | OPRX OptimizeRx Corp | FTax withholding Common Stock | -1,737 | $7.71 | $13k | 183,551 | Aug 24, 2026 |
| May 15, 2026 | OPRX OptimizeRx Corp | FTax withholding Common Stock | -5,219 | $5.21 | $27k | 185,288 | May 18, 2026 |
| Dec 23, 2025 | OPRX OptimizeRx Corp | FTax withholding Common Stock10b5-1 | -3,361 | $12.74 | $43k | 190,507 | Dec 23, 2025 |
| Dec 23, 2025 | OPRX OptimizeRx Corp | FTax withholding Common Stock | -3,361 | $12.74 | $43k | 190,507 | Dec 23, 2025 |
| Dec 19, 2025 | OPRX OptimizeRx Corp | MOption exercise Common Stock | +6,546 | $0.00 | $0 | 195,462 | Dec 22, 2025 |
| Dec 19, 2025 | OPRX OptimizeRx Corp | FTax withholding Common Stock | -1,594 | $13.51 | $22k | 193,868 | Dec 22, 2025 |
| Dec 19, 2025 | OPRX OptimizeRx Corp | MOption exercise Restricted Stock Unitsderivative | -6,546 | $0.00 | $0 | 6,547 | Dec 22, 2025 |
| Oct 3, 2025 | OPRX OptimizeRx Corp | MOption exercise Common Stock | +6,649 | $0.00 | $0 | 190,536 | Oct 7, 2025 |
| Oct 3, 2025 | OPRX OptimizeRx Corp | SOpen-market sale Common Stock | -1,620 | $18.75 | $30k | 188,916 | Oct 7, 2025 |
| Oct 3, 2025 | OPRX OptimizeRx Corp | MOption exercise Restricted Stock Unitsderivative | -6,649 | $0.00 | $0 | 0 | Oct 7, 2025 |
| Aug 21, 2025 | OPRX OptimizeRx Corp | AGrant or award Common Stock | +15,625 | $0.00 | $0 | 183,887 | Aug 25, 2025 |
| Aug 21, 2025 | OPRX OptimizeRx Corp | AGrant or award Stock Optionderivative | +35,156 | $0.00 | $0 | 35,156 | Aug 25, 2025 |
| May 15, 2025 | OPRX OptimizeRx Corp | AGrant or award Common Stock | +46,948 | $0.00 | $0 | 168,262 | May 19, 2025 |
| May 15, 2025 | OPRX OptimizeRx Corp | AGrant or award Stock Optionderivative | +80,884 | $0.00 | $0 | 80,884 | May 19, 2025 |
| Dec 23, 2024 | OPRX OptimizeRx Corp | AGrant or award Common Stock | +41,408 | $0.00 | $0 | 122,256 | Dec 27, 2024 |
| Dec 23, 2024 | OPRX OptimizeRx Corp | AGrant or award Stock Optionderivative | +77,742 | $0.00 | $0 | 77,742 | Dec 27, 2024 |
| Dec 19, 2024 | OPRX OptimizeRx Corp | MOption exercise Common Stock | +6,546 | $0.00 | $0 | 83,424 | Dec 20, 2024 |
| Dec 19, 2024 | OPRX OptimizeRx Corp | FTax withholding Common Stock | -2,576 | $4.75 | $12k | 80,848 | Dec 20, 2024 |
| Dec 19, 2024 | OPRX OptimizeRx Corp | MOption exercise Restricted Stock Unitsderivative | -6,546 | $0.00 | $0 | 13,093 | Dec 20, 2024 |
Questions about Stephen L Silvestro
Answered from the filings on this page, as of the latest one.
Is Stephen L Silvestro buying or selling?
Not in the last 12 months. Stephen L Silvestro's latest open-market trade on SEC Form 4 was sold $30k of OPRX on Oct 3, 2025.
How did Stephen L Silvestro's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Stephen L Silvestro has 0.
Where does Stephen L Silvestro file Form 4?
Stephen L Silvestro has filed Form 4 at OPRX (OptimizeRx Corp) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.